Search by Drug Name or NDC

    NDC 72426-0818-09 Nexlizet 180; 10 mg/1; mg/1 Details

    Nexlizet 180; 10 mg/1; mg/1

    Nexlizet is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Esperion Therapeutics, Inc.. The primary component is BEMPEDOIC ACID; EZETIMIBE.

    Product Information

    NDC 72426-0818
    Product ID 72426-818_eec27ac3-c444-4088-9fc0-d75e24913695
    Associated GPIs 39991002200320
    GCN Sequence Number 080790
    GCN Sequence Number Description bempedoic acid/ezetimibe TABLET 180MG-10MG ORAL
    HIC3 M4W
    HIC3 Description ANTIHYPERLIPIDEMIC-ACLY AND CHOLES ABSORP INHIB
    GCN 47765
    HICL Sequence Number 046386
    HICL Sequence Number Description BEMPEDOIC ACID/EZETIMIBE
    Brand/Generic Brand
    Proprietary Name Nexlizet
    Proprietary Name Suffix n/a
    Non-Proprietary Name Bempedoic Acid and Ezetimibe
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 180; 10
    Active Ingredient Units mg/1; mg/1
    Substance Name BEMPEDOIC ACID; EZETIMIBE
    Labeler Name Esperion Therapeutics, Inc.
    Pharmaceutical Class Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC], Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA], Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA211617
    Listing Certified Through 2024-12-31

    Package

    NDC 72426-0818-09 (72426081809)

    NDC Package Code 72426-818-09
    Billing NDC 72426081809
    Package 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72426-818-09)
    Marketing Start Date 2020-03-09
    NDC Exclude Flag N
    Pricing Information N/A